[Pangyo Bio & Medical] Theragen Bio discovers MAST4 protein that regulates bone cartilage development for ‘the first time in the world’
tecaving2022-08-03T15:38:53+09:00Screenshot of the July issue of ‘Nature Communications’ [...]
[Pangyo Bio & Medical] SK Bioscience’s “domestic no. 1 vaccine” effective against the omicron variant
tecaving2022-08-03T15:31:09+09:00Image: SK Bioscience SK Bioscience announced that Korea’s [...]
[Pangyo Bio & Medical] SK Bioscience to promise global cooperation with the Bill & Melinda Gates Foundation on COVID-19 vaccines
tecaving2022-08-03T13:54:32+09:00SK Bioscience announced on the 17th that it has discussed [...]
[Pangyo Bio & Medical] SK Bioscience to apply for domestic approval of its covid-19 vaccine, “SKYCovione, GBP510”
tecaving2022-08-03T13:18:22+09:00SK Bioscience announced on the 29th that it applied for approval [...]
![[Pangyo Bio & Medical] Genius-Kakao Healthcare to close an agreement on health care based on genetic information](https://us.aving.net/wp-content/uploads/2022/05/20220502093505_1747129_1199_818-1.jpg)
[Pangyo Bio & Medical] Genius-Kakao Healthcare to close an agreement on health care based on genetic information
tecaving2022-08-03T13:12:08+09:00Genius, a company specializing in genetic analysis, will join forces [...]
[Pangyo Bio & Medical] SK Bioscience to create a Nobel Prize in the vaccine industry
tecaving2022-08-03T10:01:51+09:00SK Bioscience would create a Nobel Prize for vaccine which [...]
[Pangyo Bio & Medical] Organoid Sciences to host a webinar on a new organoid-based drug
tecaving2022-08-03T10:09:05+09:00Organoid Sciences, a biotech company that specializes in organ analog [...]
[Pangyo Tech] SK Chemical’s “sustainable management report” to win a gold prize at the LACP vision award
tecaving2022-08-03T10:11:07+09:00SK Chemical announced on the 15th that its sustainable management [...]
[Pangyo Bio & Medical] SK Bioscience “the clinical trial result of South Korea’s first vaccine to be released in October”
tecaving2022-08-03T10:50:24+09:00SK Bioscience which is conducting phase 3 clinical trial of [...]
[Pangyo Bio & Medical]SK Bioscience holds mRNA Vaccine Patent Analysis Briefing Session
tecaving2022-08-03T11:30:34+09:00The Korean Intellectual Property Office (KIPO) held “mRNA Vaccine Patent [...]